Leadership
February 02, 2022
RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture
Cell Therapy, Investment, Partnerships
January 11, 2022
GHO Capital invests in RoslinCT, a leading cell therapy CDMO
![[Q&A] Navigating Cell Therapy Supply Chain Challenges](https://www.roslinct.com/wp-content/uploads/2023/05/Blog-407x271-8.jpg.webp)
![[EBOOK] Build Vs. Buy: A Critical Calculation for Cell Therapy Innovators](https://www.roslinct.com/wp-content/uploads/2021/12/Blog-407x271-6.jpg.webp)
Cell Therapy, eBook
December 02, 2021
[EBOOK] Build Vs. Buy: A Critical Calculation for Cell Therapy Innovators
Facilities
June 14, 2021
RoslinCT Boston’s (former Lykan Bio) State-of-the-Art, Purpose-Built Cell Therapy Facility
Facilities, Site Expansion
February 05, 2021